|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/495 | |
| A61P 25/18 |
| (11) | Number of the document | 1333832 |
| (13) | Kind of document | T |
| (96) | European patent application number | 01983555.2 |
| Date of filing the European patent application | 2001-10-16 | |
| (97) | Date of publication of the European application | 2003-08-13 |
| (45) | Date of publication and mention of the grant of the patent | 2007-11-28 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/EP2001/011952 |
| Date | 2001-10-16 |
| (87) | Number | WO 2002/040024 |
| Date | 2002-05-23 |
| (30) | Number | Date | Country code |
| 00124815 | 2000-11-14 | EP |
| (72) |
BARTOSZYK, Gerd, DE
|
| (73) |
Merck Patent GmbH,
Frankfurter Strasse 250, 64293 Darmstadt,
DE
|
| (54) | NOVEL USES OF COMBINED 5-HT1A AGONISTS AND SEROTONIN REUPTAKE INHIBITORS |
| NOVEL USES OF COMBINED 5-HT1A AGONISTS AND SEROTONIN REUPTAKE INHIBITORS |